Business Context and Reporting Period
Company: Compass Minerals International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2007
Subject: Entry into a Material Definitive Agreement (Amendment to Rights Agreement).
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a legal disclosure regarding corporate governance and shareholder rights.
Material Changes
On January 8, 2007, the Company entered into Amendment Number Two to its Rights Agreement with UMB Bank, n.a. The material changes include:
- TIDE Provision: Added a requirement for an Independent Director Evaluation. A committee of independent directors must meet no later than November 30, 2009, and at least once every three years thereafter, to determine if maintaining the Rights Agreement remains in the best interest of shareholders.
- Exempt Person Definition: Modified the definition of "Exempt Person" to remove a previous exemption granted to a specific entity and its affiliates/associates who were former majority stockholders of the Company.
Guidance, Outlook, and Risks
Management Commentary: The TIDE provision is explicitly designed to protect the Company and its shareholders from unsolicited attempts or inequitable offers to acquire the Company.
Risks and Contingencies: The filing does not disclose new operational risks, contingencies, or unusual items beyond the standard implications of a poison pill rights agreement.
Investor Verification Checklist
- Verify the full text of Exhibit 10.1 (Amendment Number Two) to understand the specific legal language of the TIDE provision.
- Confirm the identity of the "specific entity" whose exemption was removed from the "Exempt Person" definition.
- Review the composition of the Board of Directors to identify which members qualify as "independent directors" under NYSE listing standards for the evaluation committee.
- Check subsequent filings to confirm the scheduling of the first required independent director evaluation meeting.